Ramaphosa to Launch “Game-Changer” HIV Injection
President Cyril Ramaphosa is expected to launch the rollout of the lifesaving HIV prevention injectable medicine, Lenacapavir, later this week.
Lenacapavir is administered via injection twice a year, offering people six months of continuous protection per dose and providing welcome relief from daily pills or bi-monthly injections.
“This groundbreaking initiative marks a significant milestone in South Africa’s ongoing efforts to fight against HIV/AIDS and aims to enhance prevention of new HIV infections,” the Presidency said in a statement.
“Lenacapavir is a twice-yearly long-acting injectable option for HIV prevention, and the rollout highlights the collaboration between the government, civil society, the private sector, and development partners amongst the stakeholders committed to ending HIV as a public health threat in South Africa.”
Health Minister Dr Aaron Motsoaledi, Mpumalanga Premier Mandla Ndlovu, provincial Health MECs, leaders of SANAC civil society, development partners, and donors, including the Global Fund, are expected to attend the launch.
The launch will be held at the Lilian Ngoyi Stadium in Secunda, Mpumalanga, on Friday.
